1. Home
  2. XNCR vs GCMG Comparison

XNCR vs GCMG Comparison

Compare XNCR & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • GCMG
  • Stock Information
  • Founded
  • XNCR 1997
  • GCMG 1971
  • Country
  • XNCR United States
  • GCMG United States
  • Employees
  • XNCR N/A
  • GCMG N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • GCMG Finance/Investors Services
  • Sector
  • XNCR Health Care
  • GCMG Finance
  • Exchange
  • XNCR Nasdaq
  • GCMG Nasdaq
  • Market Cap
  • XNCR 547.8M
  • GCMG 631.4M
  • IPO Year
  • XNCR 2013
  • GCMG N/A
  • Fundamental
  • Price
  • XNCR $8.62
  • GCMG $12.79
  • Analyst Decision
  • XNCR Buy
  • GCMG Buy
  • Analyst Count
  • XNCR 10
  • GCMG 4
  • Target Price
  • XNCR $23.33
  • GCMG $15.13
  • AVG Volume (30 Days)
  • XNCR 726.1K
  • GCMG 443.2K
  • Earning Date
  • XNCR 11-05-2025
  • GCMG 11-07-2025
  • Dividend Yield
  • XNCR N/A
  • GCMG 3.44%
  • EPS Growth
  • XNCR N/A
  • GCMG N/A
  • EPS
  • XNCR N/A
  • GCMG 0.19
  • Revenue
  • XNCR $146,929,000.00
  • GCMG $533,097,999.00
  • Revenue This Year
  • XNCR $22.06
  • GCMG $4.88
  • Revenue Next Year
  • XNCR N/A
  • GCMG $11.78
  • P/E Ratio
  • XNCR N/A
  • GCMG $68.86
  • Revenue Growth
  • XNCR N/A
  • GCMG 15.56
  • 52 Week Low
  • XNCR $6.92
  • GCMG $10.04
  • 52 Week High
  • XNCR $27.24
  • GCMG $14.48
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 55.91
  • GCMG 53.68
  • Support Level
  • XNCR $8.25
  • GCMG $12.63
  • Resistance Level
  • XNCR $8.73
  • GCMG $12.98
  • Average True Range (ATR)
  • XNCR 0.37
  • GCMG 0.19
  • MACD
  • XNCR 0.06
  • GCMG -0.05
  • Stochastic Oscillator
  • XNCR 69.03
  • GCMG 46.72

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About GCMG GCM Grosvenor Inc.

GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.

Share on Social Networks: